Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
04 May 2020 - 8:01PM
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the
Company will release results for its first quarter of 2020 ended
March 31, 2020, after the market closes on Thursday, May 7th, 2020,
and will hold a conference call to discuss its financial results at
2:00 p.m. Pacific Time.
To access the conference call, dial toll free (877)
881-2595, or (315) 625-3083 for international callers, five minutes
before the conference. The passcode for the conference call is
9246728.
The call can also be accessed on the Investors page
on the Company’s website www.amphastar.com.
Amphastar is a specialty pharmaceutical company that primarily
develops, manufactures, markets, and sells generic and proprietary
injectable and inhalation products, including products with high
technical barriers to market entry. Most of the Company’s products
are used in hospital or urgent care clinical settings and are
primarily contracted and distributed through group purchasing
organizations and drug wholesalers.
All statements in this press release and in the conference call
referenced above that are not historical are forward-looking
statements, including, among other things, statements relating to
the Company’s expectations regarding future financial performance,
backlog, sales and marketing of its products, market size and
growth, the timing of FDA filings or approvals, including the DMFs
of ANP, the timing of product launches, acquisitions and other
matters related to its pipeline of product candidates, its share
buyback program and other future events. These statements are not
historical facts but rather are based on Amphastar’s historical
performance and its current expectations, estimates, and
projections regarding Amphastar’s business, operations and other
similar or related factors. Words such as “may,” “might,” “will,”
“could,” “would,” “should,” “anticipate,” “predict,” “potential,”
“continue,” “expect,” “intend,” “plan,” “project,” “believe,”
“estimate,” and other similar or related expressions are used to
identify these forward-looking statements, although not all
forward-looking statements contain these words. You should not
place undue reliance on forward-looking statements because they
involve known and unknown risks, uncertainties, and assumptions
that are difficult or impossible to predict and, in some cases,
beyond Amphastar’s control. Actual results may differ
materially from those in the forward-looking statements as a result
of a number of factors, including those described in Amphastar’s
filings with the Securities and Exchange Commission. You can locate
these reports through the Company’s website at
http://ir.amphastar.com and on the SEC’s website at
www.sec.gov. Amphastar undertakes no obligation to revise or
update information in this press release or the conference call
referenced above to reflect events or circumstances in the future,
even if new information becomes available or if subsequent events
cause Amphastar’s expectations to change.
Contact:
William J. PetersChief Financial Officer(909) 980-9484
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Apr 2024 to May 2024
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From May 2023 to May 2024